Clinical Trials
5 trialsNCT03143153 2026-02-17
CheckMate 648
Bristol-Myers Squibb
Phase 3 Completed
NCT02632409 2025-10-16
CheckMate 274
Bristol-Myers Squibb
Phase 3 Active not recruiting
NCT02488759 2023-11-13
CheckMate358
Bristol-Myers Squibb
Phase 1/2 Completed
NCT02387996 2022-11-01
A Study of Nivolumab in Participants With Metastatic or Unresectable Bladder Cancer
Bristol-Myers Squibb
Phase 2 Completed
NCT03130959 2022-08-09
CheckMate 908
Bristol-Myers Squibb
Phase 2 Completed